Welcome Guest | Register / Login

Biotechnology Market Research Reports

Sort By
Title Published Price Buy Now
North America Biochips Market Forecast 2019-2027
By Inkwood Research
KEY FINDINGS North America biochips market is expected to evolve with 20.89% CAGR over the forecast period of 2019-2027. Between these years, the market revenue is expected to increase from $xx million in 2018 and reach $x million by 2027. Bio...
Mar 2019 $ 1250
Emerging Jobs in Life Sciences and What You Should Be Training for Now
By BCC Research
Report Scope: Finding the right career path is one of the biggest challenges in every person's life. We want to make sure we make the right choices and decisions concerning our future employment opportunities. And it's no longer a one-...
Feb 2019 $ 995
5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2019
By Delve Insight
"5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "5-Lipoxygenase Inh...
Jan 2019 $ 1250
Aldose Reductase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Aldose Reductase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Aldose Reductase Inhibitor development. The report provi...
Jan 2019 $ 1250
Alpha-Amylase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Alpha-Amylase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Alpha-Amylase Inhibitor development. The report provides de...
Jan 2019 $ 1250
Amyloid Protein Blockers - Pipeline Insight, 2019
By Delve Insight
"Amyloid Protein Blockers - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Amyloid Protein Blockers development. The report provides ...
Jan 2019 $ 1250
Anaplastic Lymphoma Kinase (ALK) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Anaplastic Lymphoma Kinase (ALK) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anaplastic Lymphoma Kinase (ALK) Inhibit...
Jan 2019 $ 1250
Angiopoietin Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Angiopoietin Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Angiopoietin Inhibitor development. The report provides deta...
Jan 2019 $ 1250
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Angiopoietin 2 (Ang-2) Inhibitor development. The ...
Jan 2019 $ 1250
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Angiotensin Converting Enzyme (ACE) I...
Jan 2019 $ 1250
Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Angiotensin II Receptor Typ...
Jan 2019 $ 1250
Anti GM-CSF Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti GM-CSF Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti GM-CSF Antibody development. The report provides detailed...
Jan 2019 $ 1250
Anti-CD152 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD152 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD152 Antibody development. The report provides detailed c...
Jan 2019 $ 1250
Anti-CD19 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD19 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD19 Antibody development. The report provides detailed cov...
Jan 2019 $ 1250
Anti-CD28 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD28 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD28 Antibody development. The report provides detailed cov...
Jan 2019 $ 1250
Anti-CD33 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD33 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD33 Antibody development. The report provides detailed cov...
Jan 2019 $ 1250
Anti-CD37 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD37 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD37 Antibody development. The report provides detailed cov...
Jan 2019 $ 1250
Anti-CD38 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD38 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD38 Antibody development. The report provides detailed cov...
Jan 2019 $ 1250
Anti-CD40 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD40 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD40 Antibody development. The report provides detailed cov...
Jan 2019 $ 1250
Anti-CD52 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD52 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD52 Antibody development. The report provides detailed cov...
Jan 2019 $ 1250
Anti-CD80 Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-CD80 Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-CD80 Antibody development. The report provides detailed cov...
Jan 2019 $ 1250
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Dickkopf-1 (Dkk-1) Antibody development. The ...
Jan 2019 $ 1250
Anti-Lymphotoxin - Pipeline Insight, 2019
By Delve Insight
"Anti-Lymphotoxin - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Lymphotoxin development. The report provides detailed coverag...
Jan 2019 $ 1250
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2019
By Delve Insight
"Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Anti-Mucin 1 (MUC1) Antibody development. The report p...
Jan 2019 $ 1250
Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Apolipoprotein B (ApoB) Inhibitor development. Th...
Jan 2019 $ 1250
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy